Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Gain insights into the latest advances in NTRK fusion testing and recent advances in tumor-agnostic TRK inhibition through expert-guided discussion.

Share

Program Content

Activities

TRK Inhibitors
Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing
Congratulations: You achieved a completion on 04/09/2022

Activities

TRK Inhibitors: FAQ
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 14, 2020

Expires: August 13, 2021

Activities

<i>NTRK</i> Testing
Rationale for Targeting TRK Fusions in Solid Tumors and Implementing NTRK Testing in the Clinic
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

Using TRK Inhibitors
Clinical Data and Current Indications for TRK Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

TRKi Resistance/Safety
TRK Inhibitor Resistance and Safety
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

Activities

Using TRK Inhibitors
How I Use TRK Inhibitors in Patients With NTRK Fusion–Positive Tumors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

Faculty

cover img faculity

George D. Demetri, MD

Professor of Medicine
Harvard Medical School
Harvard University
Co-Director, Ludwig Center at Harvard
Senior Vice President for Experimental Therapeutics
Director,
Sarcoma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Alexander E Drilon, MD

Chief, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Pashtoon M. Kasi, MD, MS

Director 
Colon Cancer Research 
Weill Cornell Medicine
Director 
Liquid Biopsy Research 
Englander Institute of Precision Medicine 
New York, New Yotk

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Genentech TEXT Only